Literature DB >> 2175711

Chloroquine inhibition of cholera toxin.

Y F Liang1, J W Peterson, C A Jackson, J C Reitmeyer.   

Abstract

Cholera toxin (CT) stimulated adenylate cyclase and a phospholipase which elevated cellular levels of 3',5'-cyclic adenosine monophosphate (cAMP) and arachidonic acid (AA). The AA was quickly converted to prostaglandins (PGs) via the cyclo-oxygenase pathway. Chloroquine exerted minimal inhibition of cAMP levels in CT-treated cells, although CT-induced release of [3H]AA and PGs was blocked completely when the drug was added in concentrations as low as 0.1 mM (50 micrograms/ml). Inhibition of [3H]AA release was complete when chloroquine was added before or within 30 min after CT. The capacity of chloroquine to inhibit either phospholipase C (PLC) or phospholipase A2 (PLA2) could explain the antisecretory activity of this drug.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2175711     DOI: 10.1016/0014-5793(90)81459-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  5 in total

1.  Chloroquine inhibits macrophage tumour necrosis factor-alpha mRNA transcription.

Authors:  X Zhu; W Ertel; A Ayala; M H Morrison; M M Perrin; I H Chaudry
Journal:  Immunology       Date:  1993-09       Impact factor: 7.397

2.  Chloroquine-induced inhibition of the production of TNF, but not of IL-6, is affected by disruption of iron metabolism.

Authors:  S Picot; F Peyron; A Donadille; J P Vuillez; G Barbe; P Ambroise-Thomas
Journal:  Immunology       Date:  1993-09       Impact factor: 7.397

3.  Cholera toxin B subunit activates arachidonic acid metabolism.

Authors:  J W Peterson; R A Finkelstein; J Cantu; D L Gessell; A K Chopra
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

Review 4.  Chloroquine-containing compounds: a patent review (2010 - 2014).

Authors:  Paul M Njaria; John Okombo; Nicholas M Njuguna; Kelly Chibale
Journal:  Expert Opin Ther Pat       Date:  2015-06-01       Impact factor: 6.674

5.  Finding disease modules for cancer and COVID-19 in gene co-expression networks with the Core&Peel method.

Authors:  Marta Lucchetta; Marco Pellegrini
Journal:  Sci Rep       Date:  2020-10-19       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.